CERS / Down 20.4% in 4 Weeks, Here's Why Cerus (CERS) Looks Ripe for a Turnaround

Cerus Corporation (NASDAQ:CERS ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Jessica Hanover - Vice President of more_horizontal

Cerus (CERS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 more_horizontal

Cerus (CERS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 more_horizontal

While Most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the am more_horizontal

Today, we put medical device concern Cerus Corporation in the spotlight. Cerus has some current challenges, which management believes are temporary.  more_horizontal

Cerus (CERS) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.07 more_horizontal

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2023 financial results will be released on T more_horizontal

Cerus Corp (NASDAQ:CERS ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Joel Trujillo - Senior Director, IR Willi more_horizontal